Idioma:

Dietary supplementation of micro-encapsulated sodium butyrate in healthy horses: effect on gut histology and immunohistochemistry parameters

Wambacq, W A ; van Doorn, D A ; Rovers-Paap, P M ; Ducatelle, R ; Vlaminck, L ; Lourenço, M ; Hesta, M

BMC veterinary research, 2020-04, Vol.16 (1), p.121-121, Article 121 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Dietary supplementation of micro-encapsulated sodium butyrate in healthy horses: effect on gut histology and immunohistochemistry parameters
Autor: Wambacq, W A ; van Doorn, D A ; Rovers-Paap, P M ; Ducatelle, R ; Vlaminck, L ; Lourenço, M ; Hesta, M
Assuntos: Acidification ; Acidosis ; Animal Feed - analysis ; Animals ; Body weight ; Butyrate ; Butyrates - pharmacology ; CD20 antigen ; CD3 antigen ; Cell growth ; Colon ; Diet ; Diet - veterinary ; Dietary supplements ; Digestion - drug effects ; Digestive system ; Digestive tract ; Equine ; Esters ; Feces ; Female ; Gastrointestinal diseases ; Gastrointestinal Tract - cytology ; Gastrointestinal Tract - drug effects ; Histology ; Horses ; Hydrogen-Ion Concentration ; Immunohistochemistry ; Intestinal Mucosa - drug effects ; Large intestine ; Male ; pH effects ; Sodium butyrate ; Starch ; Studies ; Villus
É parte de: BMC veterinary research, 2020-04, Vol.16 (1), p.121-121, Article 121
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: As colic and intestinal disorders are a major concern in horses, the aim of the present study was to investigate the effect of dietary supplementation of butyrate, known to have a diverse array of beneficial effects on intestinal health. The effect of micro-encapsulated sodium butyrate supplementation on gut histology and immunohistochemistry parameters was studied in 14 healthy warmblood horses destined for slaughter in two separate periods. Horses were fed a low fiber - high starch diet, designed to induce subsequent starch overflow in the large intestine, aiming to create a mild challenge for large intestinal health. Treatment included supplementation with either micro-encapsulated sodium butyrate (Excential Butycoat®, Orffa, Werkendam, the Netherlands) or placebo (containing only coating material). The horses were fed for 20 consecutive days at a dosage of 0.4 g/kg BW (body weight). At day 21, the horses were slaughtered and intestinal samples were collected for determination of gut pH, villus length, crypt depth and area % of CD3+ and CD20+ cells. Horses on the butyrate supplemented diet had significantly reduced crypt depths in the right dorsal colon compared to placebo-fed horses (P < 0.001). However, a treatment x period interaction (P = 0.002) was discovered regarding this parameter, which could not be explained by the authors. Further investigation into the number of KI67+ cells in the RDC crypts did not reveal any significant differences between treatments (P = 0.650), indicating that the reduction in crypt depth in butyrate-fed horses could not be explained by a significant difference in cellular proliferation. Intestinal pH, villus length and expression of intestinal CD3+ and CD20+ cells were not significantly affected by treatment at any intestinal level. Our data indicate that supplementation of micro-encapsulated sodium butyrate to the equine diet did not influence gut histology (with the exception of a decrease found in the crypts of the RDC) or immunohistochemistry parameters in healthy horses. Further research is warranted to investigate the impact of butyrate supplementation in horses with intestinal disease.
Editor: England: BioMed Central Ltd
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Dietary supplementation of micro-encapsulated sodium butyrate in healthy horses: effect on gut histology and immunohistochemistry parameters

Wambacq, W A ; van Doorn, D A ; Rovers-Paap, P M ; Ducatelle, R ; Vlaminck, L ; Lourenço, M ; Hesta, M

England: BioMed Central Ltd

Buscando em bases de dados remotas. Favor aguardar.